Compare Boston Scientific Corporation (BSX) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs HP Inc — how do they compare? Boston Scientific Corporation trades at $42.62 (market cap $66.37B), while HP Inc trades at $24.66 (market cap $22.52B). The key difference: Boston Scientific Corporation is far larger — about 2.9× HP Inc's market cap, and HP Inc pays a 4.87% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | HPQ | |
|---|---|---|
Market Cap | $66.37B | $22.52B |
Sector | Health | Technology |
52-Week High | $108.14 | $29.35 |
52-Week Low | $42.63 | $18.20 |
Enterprise Value | $75.94B | $29.69B |
Dividend Yield | — | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
HPQ trades at $24.77, up 2.27% today, with a bullish technical outlook and strong earnings momentum, beating estimates for three consecutive quarters. The stock offers a 4.8% dividend yield and trades at attractive valuation multiples, including a P/E of 9.17 and P/S of 0.41. Recent partnerships with OpenAI and Ferrari highlight strategic moves to enhance AI capabilities and innovation in the PC market.
The outlook is positive due to undervaluation, dividend income, and AI-driven growth potential, but risks include PC market volatility, competitive pressures, and reliance on hardware sales. Analyst consensus is mixed with a hold rating, but technical indicators suggest near-term strength with support at $24 and resistance at $25-26.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
